Sigma Planning Corp Mustang Bio, Inc. Transaction History

Sigma Planning Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$2.7 - $3.81 $241,447 - $340,709	-89,425 Closed	0 $0
Q1 2021 May 06, 2021	SELL	$3.02 - $5.16 $40,730 - $69,592	-13,487 Reduced 13.11%	89,425 $297,000
Q4 2020 Feb 09, 2021	BUY	$2.66 - $4.18 $35,944 - $56,484	13,513 Added 15.12%	102,912 $390,000
Q3 2020 Nov 03, 2020	SELL	$3.01 - $3.88 $51,124 - $65,901	-16,985 Reduced 15.97%	89,399 $282,000
Q2 2020 Jul 31, 2020	BUY	$2.33 - $4.6 $247,874 - $489,366	106,384 New	106,384 $338,000

415K

Ticker MBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,222,000
Market Cap $17.9M
Description
Mustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on translating medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline focuses on gene therapy programs for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (...

Get notified when there are updates to the investment portfolio of Sigma Planning Corp, based on Form 13F filings with the SEC.

Stay updated on Sigma Planning Corp with notifications on news.